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1. Introduction 
The arenaviruses are part of a growing viral family denominated Arenaviridae. Currently, 
there are 22 recognized members (Salvato et al., 2005), listed in Table 1. Based on the 
geographic origin and distribution of their hosts, the arenaviruses can be classified in two 
groups: the New World Arenaviruses (NWA) and the Old World Arenaviruses (OWA). The 
first group comprised native American arenaviruses, while the Old World group is 
conformed by African viruses and the ubiquitous Lymphocytic Choriomeningitis virus 
(LCMV). This geographic distribution is determined by the species host range, with LCMV 
as the only one arenavirus with a worldwide distribution, mainly because Mus musculus is 
its rodent reservoir. Specific members of Neotominae and Sigmodontinae from the Cricetidae 
rodent’s family are the principal hosts for the New World Arenaviruses (Cajimat et al., 2007). 
From these 22 recognized species, only 6 were consistently detected in humans and were 
related to a set of clinical symptoms that allowed to establish the description of a disease: 
Lymphocytic Choriomeningitis (LCM, caused by LCMV), Lassa Fever (LF caused by LASV), 
Argentine Hemorrhagic Fever (AHF, caused by JUNV), Bolivian Hemorrhagic Fever (BHF, 
caused  by MACV), Venezuelan Hemorrhagic Fever (VHF, caused by GTOV), and Brazilian 
Hemorrhagic Fever (BrHF, caused by SABV). The physiopathology of the hemorrhagic 
fevers produced by NWA is very similar. AHF and BHF were described in the middle of the 
twentieth century. GTOV was isolated from humans during an epidemic outbreak (at first 
mistaken for hemorrhagic dengue) that happened in Venezuela (Salas et al., 1991). Because 
GTOV and PIRV share the same (geographic) area, different studies were made with the aim 
of predicting a re-emergence of a Venezuelan hemorrhagic fever variant (Cajimat & 
Fulhorst, 2004). The Brazilian hemorrhagic fever was established from a human fatal case, 
isolating the SABV (Lisieux et al., 1994). Recently, a serological screening for arenavirus 
among the population of Nova Xavantina, State of Mato Grosso in Brazil, show that 1,4% of 
the serum samples presented antibody titers against arenavirus (Machado et al., 2010). 
In 2003 a hemorrhagic fever case was reported in Bolivia, and after an exhaustive analysis a 
new virus, denominated Chapare, was described (Delgado et al., 2008). On the other side, in 
the year 2000, another three isolated cases were reported, one of them, related to WWAV, 
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was a classical hemorrhagic fever (CDC, 2000), while the others, related to TCRV and FLEV, 
were mild feverish illness in laboratory workers (Charrel et al., 2008).  
 
Virus Acronym
Evolutionary 
Lineage 
Distribution Reservoir 
Human 
Disease 
Flexal FLEV NWA-A Brazil Oryzomys spp. LM 
Pichindé PICV NWA-A Colombia O. albigularis NR 
Paraná PARV NWA-A Paraguay O. buccinatus NR 
Allpahuayo ALLV NWA-A Perú Oecomys bicolor NR 
Pirital PIRV NWA-A Venezuela Sigmodon alstoni NR 
Junín JUNV NWA-B Argentina C. musculinus SD 
Machupo MACV NWA-B Bolivia C. callosus, C. laucha SD 
Guanarito GTOV NWA-B Venezuela Z. brevicauda SD 
Sabia SABV NWA-B Brazil Unknown LS 
Chapare - NWA-B Bolivia Unknown LS 
Pinhal - NWA-B Brazil Calomys tener NR 
Tacaribe TCRV NWA-B Trinidad Artibeus spp. LM 
Cupixi CPXV NWA-B Brazil O. capita NR 
Amapari AMAV NWA-B Brazil O. capita-N. guianae NR 
Oiveros OLVV NWA-C Argentina Bolomys obscurus NR 
Pampa - NWA-C Argentina Bolomys sp. NR 
Latino LATV NWA-C Bolivia Calomys callosus NR 
Río Carcarañá - NWA Argentina Bolomys obscurus NR 
Catarina - NWA-RecA/B USA, Texas Neotoma micropus NR 
Skinner Tank - NWA-RecA/B USA, Arizona Neotoma mexicana NR 
North American - NWA-Rec A/B USA Neotoma mexicana NR 
Withewater 
Arroyo 
WWAV NWA-RecA/B USA, Southwest N. albigula, N. mexicana LS 
Tamiami TAMV NWA-RecA/B USA, Florida Sigmodon hispidus NR 
Bear Canyon BCNV NWA-RecA/B USA, California Peromyscus sp. NR 
Big Brushy Tank - NWA-Rec A/B USA   
Tonto Creek - NWA-Rec A/B USA   
LCM LCMV OWA All world Mus musculus MD 
Lassa LASV OWA 
Nigeria, Ivory 
Coast, Guinea, 
Sierra Leone 
Mastomys sp. SD 
Mopeia MOPV OWA Mozambique Mastomys natalensis NR 
Mobala MOBV OWA 
Central African 
Republic 
Praomys sp. NR 
Ippy IPPYV OWA 
Central African 
Republic 
Arvicanthis sp. NR 
Dandenong - OWA Australia Unknown LM 
Kodoko - OWA Guinea Mus Nannomys minutoides NR 
Morogoro - OWA Tanzania Mastomys sp. NR 
Lujo - OWA South Africa Unknown LS 
SD: Severe disease; MD: Mild disease; LS: Limited and severe disease; LM: Limited and mild disease; 
NR: not reported; OWA: Old World Arenavirus; NWA: New World Arenavirus; thereafter is indicated 
the lineage in which the New World members are classified: A, B, C and Rec A/B. The countries are 
listed based on viral isolation and not serology data. Table modified from Charrel & de Llambarie, 2003 
and Charrel et al., 2008. 
Table 1. Arenaviridae family members list. 
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Fig. 1. Geographic distribution of New World Arenaviruses. The black points indicate those 
viruses not described as human pathogens, while the red points indicate the known pathogens 
that cause the different American hemorrhagic fevers. After each viral acronym, the year of 
isolation or description is added. The viruses identified after the year 2000 are shadowed in 
green, while those isolated in the past century’s ´90s decade are in violet. The virus acronyms 
are indicated in Table 1, with the exception of the following: ChapV (Chapare), PamV 
(Pampa); RíoV (Río Carcarañá); PinhV (Pinhal); CatV (Catarina); NortAmV (North American); 
BigBTV (Big Brushy Tank); TontCV (Tonto Creek); and SkinTV (Skinner Tank), because they 
were not yet included as recognized arenavirus member. 
In the course of the year 2008 the Dandenong virus was characterized, isolated from a 
transplanted patient, showing a high homology with LCMV (Palacios et al., 2008).  In that 
same year an outbreak of human nosocomial disease was reported in South Africa, with a 
high mortality rate (80%) and whose etiological agent was later characterized as an 
arenavirus. After 30 years, a new emerging member of the OWA group that caused a 
hemorrhagic fever (Briese et al., 2009) was discovered. This virus was denominated Lujo 
virus, because the places where the first patients came from, the cities of Lusaka and 
Johannesburg. As can be seen in Figure 1, there is an evident increase in the information 
about arenavirus circulation in different places, with surprising findings in North America. 
Probably, their description is due to the active rodent capture program in different regions 
of USA and the search for arenaviral sequences by molecular techniques (with or without 
viral isolation). Most of these viruses still have to undergo taxonomic classification. 
The LCM virus, detected in humans and rodents (Armostrong & Sweet, 1939; Lepine et al., 
1937; Rivers & Scott, 1935), is the causative agent of lymphocytic choriomeningitis and 
although it was associated to aseptic meningitis their infections in humans are unapparent 
in most cases. This virus has been a very important tool in the description of immunological 
mechanisms (Oldstone, 1987a, 1987b). The other arenaviruses, with the exception of LCMV, 
are found in restricted areas around the world. In fact, LCMV was also isolated in the AHF 
endemic region (Maiztegui et al., 1972; Sabattini, 1977), where other arenavirus isolations  
were made, including OLVV and PamV which could be a variety of the same viral species. 
Another yet not completely characterized virus isolated in the AHF endemic area was 
www.intechopen.com
 Point Mutation 
 
162 
denominated Río Carcarañá, and from the sequence data it could be a product of a 
recombination event between arenaviruses from lineages B and C. The arenavirus 
hemorrhagic fevers are characterized by a disease that develops in well-defined phases: 
prodromal, neurologic-hemorrhagic and convalescent (Enría et al., 2004), with a short 
incubation period, high fever, headaches and a set of specific symptoms that depend on the 
arenavirus species related with the infection. The principal characteristics of the arenaviral 
hemorrhagic fevers are indicated in Table 2. 
 
Agent (Virus) Pathological Characteristics 
Old World 
Lassa 
Incubation: 3 to 21 days. Fever, headaches, myalgia, backaches, trembling and 
sickness. Generalized infection: hemorrhagic dissemination of the virus to several 
organs and systems via bloodstream, lymphatic system, respiratory and digestive 
tract. Black vomit, aqueous diarrhea (dehydration), decrease in quantity of 
lymphocyts and platelets, mild thrombocytopenia, abdominal, pleuritic and 
hepatic area pain. Extensive reticuloendothelial compromise: capillary injuries 
causing stomach, small intestine, kidneys, lungs and brain bleeding. Multifocal 
hepatocellular necrosis with Councilman-like bodies, hepatocites citoplasmatic 
degeneration and minimal inflammatory response. Adrenal focal necrosis and 
citoplasmatic inclusions. 
Respiratory system: interstitial pneumonia, cough, dyspnea, bronchitis, 
pneumonia and pleurisy. Cardiovascular system: pericarditis, tachycardia, 
bradycardia, hypertension, hypotension, thrombocytopenia, leukopenia and 
hiperuraemia, lymphadenopathy, elevated aminotransferases, decreased 
prothrombin levels, disorder of blood circulation and bleeding through the skin, 
lungs, gastrointestinal tract and other membranes mucosa. Nervous system: 
encephalitis, meningitis, uni- or bilateral hearing decrease, or convulsions. 
New World 
Junín 
Machupo 
Guanarito 
Sabiá 
Incubation: 6 to 14 days. First 4: decaying, fever, anorexia, nausea and vomiting, 
headaches and myalgia. Second stage: acute hemorrhagic syndrome (epistaxis and 
hematemesis, Melcom & Herskovits, 1981), or acute neurologic syndrome (Rugiero 
et al., 1960). General: malaise, high fever, severe myalgia, anorexia, back pain, 
abdominal tenderness, conjunctivitis, retro-orbital pain, photophobia, and 
constipation.  
Acute phase of infection: lymphomonocytes periferic blood viral active replication 
(Ambrosio et al., 1986). Oropharyngeal enanthem. Gums swollen, congested and 
bleeding (gingival border). Proteinuria high dehydration and hemoconcentration. 
In women, early menorrhagia. Multifocal hepatocellular necrosis with formation 
of Councilman-like bodies, nuclear pyknosis, cytoplasmic eosinophilia, cytolysis, 
inflammation and a mild cellular infiltration composed of mononuclear cells and 
neutrophils. Kidney damage: distal tubular cells and collecting ducts. Glomeruli or 
proximal tubules (Cossio et al., 1975). In a few cases the presence of renal failure 
was described (Agrest et al., 1969). Cardiovascular system: postural hypotension 
and relative bradycardia, arrhythmias are transient and benign. Different degrees 
of dehydration, uremia, proteinuria, hematuria and oliguria. 
Respiratory: dry cough, without sore throat. Pharyngeal enanthem broncho-
pulmonary unchanged. Interstitial pneumonia or bronchial, pulmonary edema 
and hemorrhage. 
Table 2. Arenaviral hemorrhagic fevers pathological characteristics. The principal pathological  
characteristics caused by Old World Arenaviruses (LASV, Lassa Fever), and New World 
Arenaviruses (JUNV, Argentinean Hemorrhagic Fever; MACV, Bolivian Hemorrhagic Fever; 
GTOV, Venezuelan Hemorrhagic Fever; SABV, Brazilian Hemorrhagic Fever) are listed. 
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As previously described, Argentine hemorrhagic fever (AHF) is a severe endemoepidemic 
disease characterized by vascular, renal, hematological, neurological, and immunological 
alterations with a mortality of 15 to 30% in untreated individuals. Since the disease was first 
recognized, annual outbreaks have occurred without interruption, principally in autumn 
and winter (Ambrosio et al., 2006). In Figure 3 it is possible to see the number of notified and 
confirmed cases until 2008 (Enría et al., 2008; Iserte et al., 2010). In this figure, the black arrow 
indicates the start of vaccination of the population at risk at the endemic area, reflecting the 
decrease in the AHF annual case numbers. The vaccine efficacy for the 1992-2000 periods 
was estimated in a 98% (AHF National Control Program, 2007). 
 
The arrow indicates the start of vaccination. 
Fig. 3. AHF notified and confirmed cases (1958–2006). 
The attempts to obtain a vaccine against AHF started in 1959. A collaborative effort 
conducted by the US and Argentine Governments led to the production of a live attenuated 
Junin virus vaccine. After rigorous biological testing in rhesus monkeys, the highly 
attenuated Junin virus variant, named Candid#1, was used in human volunteers, followed 
by an extensive clinical trial in the AHF endemic area. (Barrera Oro & Eddy, 1982, Maiztegui 
et al., 1987). The vaccination consists in the administration of JUNV Candid#1 to generate 
the protective immune response. The diagram with the passage history in different systems 
until the attenuated strain was obtained can be observed in Figure 4. Records of the passage 
history of the XJ strain come from the Yale Arbovirus Research Unit, Connecticut, USA (J. 
Casals) and USAMRIID, Frederick, Maryland, USA (J. G. Barrera Oro). The phase I and II 
clinical studies were made between 1984 and 1988 in Argentine and USA. After these 
studies it was shown that Candid#1 is innocuous, because none of the inoculated volunteers 
presented alterations and the immunogenicity was demonstrated in 90% of the cases. Since 
2005 the vaccine is being produced in the National Institute of Viral Human Diseases 
(INEVH) located in Pergamino city, Argentina.  
For other arenaviruses, was not yet possible to obtain an effective vaccine to prevent the 
disease. This would be especially important for Lassa fever, which is endemic in West Africa 
with up to 500.000 reported cases (Ogbu et al., 2007).  In the effort to make an efficient 
vaccine to combat Lassa fever in Africa, several strategies were applied. One of them, is 
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based upon generation of a reassortant virus that contains a genomic segment from Mopeia 
virus (non pathogenic) and the other segment from Lassa virus (Lukashevich et al., 2005). 
The obtained results are promising, but still have to demonstrate coverage of all natural 
variants of Lassa virus to ensure the protective capacity of a vaccine. 
 
Fig. 4. Passage history of Junín virus, strain Candid#1.  The genealogical relationships of the 
studied Junín virus strains are shown by arrows. The XJ strain was subjected to two 
passages in guinea-pigs (GP2) and 43 passages in mouse brain (MB43). Passage number 43 
was amplified by one round of mouse brain injection (XJ#44). This brain homogenate was 
used to infect FRhL-2 cells. After 12 passages, one pseudo single burst growth was carried 
out, followed by cloning using two limiting dilution steps. After one amplification round, 
master and secondary seeds were obtained. The vaccine stock (Candid#1) was obtained by 
single amplification of the secondary seed. The lethality index was calculated as log10 p.f.u. 
that produce one LD50 (±1 SD) by intracerebral inoculation of mice (Parodi et al., 1958). 
2. Molecular features of arenaviruses 
All arenaviruses shared morphological and biochemical properties. They are enveloped and 
their genome is composed of bipartite RNA (Martínez Segovia & Grazioli, 1969; Riviere et 
al., 1985b). These RNAs are single-stranded and posses an approximate length of 7 kb (L 
RNA) and 3,5 kb (RNA S). The lipid envelope contains two viral glycoproteins, G1 and G2, 
inside of the virion there are three other arenavirus proteins, denominated N, Z and L. The 
majority of N protein is associated to the viral RNAs forming the nucleocapsids. The second, 
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a protein of 11 kDa, is denominated Z because it has a Zinc finger structural motif and could 
be the counterpart of the matrix proteins of other RNA viruses (Pérez et al., 2003). 
Furthermore, all virions contain a minimal proportion of a RNA dependent RNA 
polymerase, denominated L protein. 
Each RNA segment directs the synthesis of two proteins; their open reading frames are 
arranged in opposite orientations (ambisense coding strategy) and are separated by a non-
coding intergenic region that folds in a stable secondary structure (Auperin et al., 1984). 
Furthermore, the ends of both genomic RNAs are complementary. The first 19 nucleotides at 
the 3' end base-pair with the complementary sequence at the 5' end forming a panhandle 
structure, which is conserved among the arenaviruses. The S RNA codes for the major 
structural proteins of the virion: the precursor of the envelope glycoproteins (GPC) and the 
viral nucleocapsid protein (N). Posttranslational cleavage of GPC renders a signal peptide 
(SP) and the two viral glycoproteins (G1 and G2). The L RNA segment codes for the viral 
RNA dependent RNA polymerase (L) and the small protein (Z). N and L proteins are 
translated from anti-genome-sense mRNAs, complementary to the 3’ portion of the viral S 
or L RNA, respectively. The GPC and Z proteins are translated from viral or genome-sense 
mRNAs corresponding to the 5’ region of the viral S or L RNA, respectively. 
The secondary and tertiary structures present in the viral genomic RNAs play an essential 
regulatory role during the transcription, translation and assembly of new viral particles 
(Álvarez et al., 2005). The intergenic region in both genomic fragments is arranged into a 
stable hairpin loop structure, which is crucial in the regulation between transcription and 
replication of the viral genome (Tortorici et al., 2001b), while the panhandle structure at the 
ends of the genomic RNAs, could act as a promoter initiating replication, as occurs in 
Flavivirus (Álvarez et al., 2005; Pérez & de la Torre, 2003; Salvato & Shimomaye, 1989). 
In Figure 5, the morphological characteristics of the arenavirus  particles are shown. They 
are pleomorphic with a diameter of 50 to 300 nm (Dalton et al., 1968; Gschwender et al., 1975; 
Murphy et al., 1968, 1970; Murphy & Whitfield, 1975; Ofodile et al., 1973; Speir et al., 1970). 
Once the virus enters the cell the ribonucleoproteins are released into the cytoplasm, and, 
transcription and replication are mediated by the L protein within the cytoplasm. The 
glycoproteins and Z are co-translated and processed in the ER and Golgi, while the N, and L 
proteins are translated on free ribosomes. Virus assembly initiates at the Golgi or plasma 
membrane. The N and L mRNAs are transcribed from the RNA S or L 3´ end, respectively. 
On the contrary, the GPC and Z mRNAs are transcribed from the 3’ end of the antigenomic 
S or L RNA. These processes and mechanisms are detailed in Figure 6.  
The genomic S RNA is transcribed to only two antigenomic forms: the 1,8 kb N mRNA and 
the 3,4 kb full length antigenomic S RNA. This antigenomic S RNA serves as the replicative 
form of the virus and also as the template for GPC mRNA transcription. When translation is 
inhibited, transcription of Junín virus S RNA yields only the N mRNA. Apparently, the non-
coding intergenic region form a secondary very stable hairpin loop acting as a transcription 
terminator (Franze Fernández et al., 1987; Ghiringhelli et al., 1991; Tortorici et al., 2001a). This 
implies that the synthesis of a full length antigenomic copy of S RNA requires an 
antiterminator. This function is supplied by the N protein (Tortorici et al., 2001a). 
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Fig. 5. Arenavirus viral particle.A. Virion structure diagram. The arenavirus particles have a 
lipid bilayer envelope (red lines), with envelope glycoprotein’s (G1 and G2), and internal 
components that include two circular nucleocapsids with bead aspect, associated to the viral 
polymerase (L), cellular messengers and ribosomes. The nucleocapsids contain RNAs S and 
L and proteins (N, in several copies and L in few copies). The Z protein is found associated 
to the bilayer by the inner face. B. Electronic micrograph of a section showing a virion 
budding from an infected Vero cell. The viral envelope is more dense and different to the 
host cell membrane. The ribosomes are presents in the budding particle (173.000 X, Murphy 
et al., 1968). C. Electronic micrograph of Junín virus particles in the extracellular space on the 
periphery of infected Vero cells (95.000 X). The particles are constituted by a heavy 
membrane envelope, containing several dense granules of 20 to 25 nm (Murphy et al., 1970). 
The glycoprotein precursor is processed into 3 peptides: the peripheral protein G1, the trans-
membrane G2 and the signal peptide (Buchmeier & Oldstone, 1979; York et al., 2004). Due to 
their characteristics, G1 is the protein that interacts with the cellular receptor. The Old 
World and C clade of New World arenaviruses share the same cellular receptor, the -
distroglycan (Cao et al., 1998; Spiropoulou et al., 2002). Later, it was found that for clade B of 
the New World arenaviruses, the receptor is a protein: the transferrin 1 receptor (TfR1, 
Radoshitzky et al., 2007).  
The arenavirus nucleoprotein has a weight of 63kDa and constitutes the principal 
component of the nucleocapsid, being the most abundant protein in the virion (near to 70%). 
This protein presents a dual function: structural and non-structural. On one side, it is 
involved in essential genome replication steps promoting the synthesis of the full length 
antigenomic segments, and on the other side it is associated to the viral genome to form the 
nucleocapsid. For that, the determinations of N-RNA interactions are very interesting study 
targets. Among the N described motifs, there is one RING finger domain whose folding 
requires zinc (Tortorici et al., 2001b). There is one conserved region between amino acids 497 
and 530 (C497X2H500X23C525X4C530, Parisi et al., 1996) and their function was experimentally 
studied (Tortorici et al., 2001b). These results confirm the identity of the domain and also  
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Fig. 6. Arenavirus replication/transcription strategy. The S and L genomic segments are 
schematized as horizontal rectangles. The ORFs that present a genomic or viral polarity (GPC 
and Z) are violet, while the antigenomic or viral complementary genes (N and L) are in green. 
The intergenic region (IGR) and untranslated terminal regions (UTR) are shown in gray. A. S 
RNA replication/transcription diagram. B. L RNA replication/transcription diagram. 
showed the possibility of the presence of other motifs that enhance this activity. Another 
important functional aspect of the N protein is its capacity to avoid elimination by the 
adaptative immune response of the host. It was demonstrated that in LCMV infections, N 
inhibits the response by β-interpheron production interference (Martínez-Sobrido et al., 2006). 
The major ORF in the virus genome corresponds to the RNA dependent RNA polymerase 
denominated L protein. In the virion, this protein is associated to the viral nucleocapsid 
forming the ribonucloeprotein complex, and posseses the sequence motifs characteristically 
conserved between the RNA dependent RNA polymerases of the negative-stranded RNA 
viruses. The polymerase activity requires oligomerization through the formation of a L-L 
complex that is essential for the enzymatic function (Sánchez & de la Torre, 2005). Because 
of its size this protein is the target for different mutations that affect its capacity to different 
extents. 
Finally, the smaller protein of this viral family is denominated Z protein. The role of Z in the 
virus life cycle is not completely elucidated, and homologues of Z are not found in other 
ambisense or negative-stranded RNA viruses. Z is a structural component of the virion 
(Salvato et al., 1992), and by means of in vivo and in vitro experiments, the interaction of Z 
with several cellular factors has been reported, including the promyelocytic leukemia 
protein and the eukaryotic translation initiation factor 4E (Borden et al., 1998a, b). Because of 
this latter interaction, it was proposed that Z inhibits Cap-mediated translation (Campbel et 
al., 2000; Kentsis et al., 2001). Other researchers suggested that Z could be a transcriptional 
regulator of the viral cycle (Garcín et al., 1993) or even an inhibitor of viral replication (López 
et al., 2001). Furthermore, Pérez and coworkers (Pérez et al., 2003) proposed, for LCMV and 
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LASV, that Z is the functional counterpart of the matrix proteins found in other negative-
stranded enveloped RNA viruses. Z protein have characteristic late domains (LDs), also 
found in matrix proteins from negative-stranded RNA viruses and in Gag protein from 
retroviruses. LDs, have an essential role in the viral budding process (Freed, 2002). Three 
types of motifs have been defined within viral LDs: P[TS]AP, PPxY, and YxxL (Pornillos et 
al., 2002), where ‘‘x’’ is any amino acid. Later, Martín Serrano and coworkers (Martín 
Serrano et al., 2004), redefined the last as: YPxL/LxxLF. LDs are highly conserved and have 
been shown to mediate interaction with host cell proteins, in particular with members of the 
vacuolar protein-sorting pathway (Bieniasz, 2006; Urata et al., 2006). For instance, the PTAP 
motif from Ebola virus VP40 matrix protein and from HIV Gag protein interacts with 
Tsg101, a member of the vacuolar protein-sorting pathway. 
3. Sequence analysis of the Junín virus vaccine related strains 
To characterize the mutations associated with the attenuated phenotype in Junín virus, we 
obtained the complete nucleotide genomic sequence from the vaccine genealogy related 
strains and another field strains of Junin virus (Goñi et al., 2006, 2010).  
Sequence data was analyzed using a series of bioinformatics tools. When we compared the 
complete genomic sequence of Candid#1, XJ#44 and XJ13 strain, we found a set of 
differences that could be associated with the attenuated phenotype (Figure 7). Alignment of 
the coding sequences of the S RNA genes of Junín virus vaccine related strains showed 
twelve nucleotide changes implied in amino acid substitutions. As depicted in Figure 7.A.1, 
one of these changes is found in the signal peptide (I35VV), four of them are at the 
middle portion of G1 (T168AA; E186EG; S206SP and P208LL), two are at the 
carboxyl terminus of G2 (F427FI and T446TS), and five more are at the amino half of 
N (V47VE; K59RR; I158VV; E268DD and T322II). An alignment of the 
coding sequences of the L genes of Junín virus strains showed only nine nucleotide changes 
between XJ13, XJ#44 and Candid#1 strains implicated in amino acid substitutions (Figure 
7.B.1). Seven of these changes may be related with the attenuation process (H76YY; 
V415VA; D462NN; L936LP; R1156KK; S1698SF and I1883IV) and two 
changes (R881GR; S921GS) could be considered reversions. All these changes are 
presented as XJ13 residue  XJ#44 residue  Candid#1 residue. On the contrary, no 
changes were found in the amino acid sequence as well as at the nucleotide level of the Z 
protein, among these three Junín virus strains. 
3.1 Mutation analysis 
Furthermore we compared the nucleotide sequences obtained from vaccine related strains 
with other reported Junín virus strains. There are only two other Junín virus strains whose 
genome was fully sequenced, Romero and MC2 strains. Romero strain, classified as a high 
virulence strain, was isolated from an AHF patient and was passed twice in fetal rhesus 
lung cells and once in Vero cells (McKee et al., 1985; Yun et al., 2008). This strain is named 
Rumero in Genebank, but this was derived from a typographical mistake. On the other 
hand, the MC2 strain was isolated from a rodent from the endemic area of AHF, and was 
classified as intermediate virulence strain (Berría et al., 1967; Candurra et al., 1989; 
Weissenbacher et al., 1987). Moreover the complete S RNA and Z gene sequences were 
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obtained for the Junín virus strain Cba-IV4454. This strain, classified as an intermediate 
virulence strain, was isolated from an AHF patient. Differences between deduced amino 
acid sequences from the six analyzed Junín virus strains are shown as vertical bars in Figure 
7 and were classified into two types: 
Type 1: Positions where the nucleotide or aminoacid sequence of one of the field strains of 
Junin virus (XJ13, Romero, IV4454 or MC2) was different from all other field strains, shown 
as vertical gray bars in Figure 7 located below each RNA scheme.  
Type 2: Positions with mutations among the vaccine strains, shown as vertical red bars in 
Figure 7 located over each RNA scheme.  
 
 
Fig. 7.  Schematic of the changes detected in Junín virus proteins. Comparisons were done 
among all fully sequenced genomes from different Junín virus strains. A nucleotide rule is 
depicted below the diagram to facilitate the location of each position. A. S RNA, 1: the open 
reading frames corresponding to the N and GPC genes are shown as open rectangles with 
arrowheads indicating the direction of translation. Non-coding sequences are shown as 
horizontal thin lines. The three cleavage products of GPC protein are shown by horizontal 
lines below the diagram. Amino acid changes detected between vaccine genealogy strains 
(XJ13, XJ#44, and Candid#1; type-2 mutation) are represented as vertical red lines over the 
genes. Above them, the detected changes and the position are indicated. Amino acid 
changes between field strains of Junín virus (XJ13, Romero, IV4454 and MC2; type-1 
mutation) are indicated as vertical lines below the genes; 2: plot of relative mutation 
frequency for type-1 mutations (blue areas) and for type-2 mutations (red line). B. L RNA, 1: 
the open reading frames corresponding to the Z and L genes and the position of the changes 
in the amino acid sequence are shown as in (A.1.). The four conserved regions of the RNA 
polymerase of arenaviruses as described by Vieth et al. (Vieth et al., 2004) are shown by 
horizontal lines below the diagram of the L RNA. Inside region III, the polymerase domain 
is signalized with an open box; 2: plot of relative mutation frequency for type-1 mutations 
(blue areas) and for type-2 mutations (red line). 
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To identify those type 2 mutations that could be more confidently related with the attenuation 
process, we compare the homologous positions at the genomes obtained from field strains of 
Junín virus (XJ13, Romero, IV4454 and MC2). At positions GPC35, N158, N268 and N322 the same 
variations present between vaccine related strains was found among field strains. At positions 
L881 and L921, there is a variation from XJ#44 to Candid#1. However, Candid#1 derived 
sequence is identical to the field strains (including XJ13) derived sequences. Thus, it is 
probable that these positions represent naturally generated mutations, non-related with the 
attenuation process. Furthermore, sequence variations among field strain are subject to natural 
selection pressure, whereas sequence variations among vaccine genealogy strains were 
subjected to an arbitrary selection pressure. We calculated a mutation frequency index defined 
as number of mutations per amino acid, and the graph was constructed with a program 
designed in our group by J.A. Iserte (unpublished results), using an overlapped windows-
based strategy (11 residues) counting the number of mutations over each window and plotting 
the value at the middle of the window. This analysis was made along the Junín virus genome 
for both types of mutations (Figure 7.A.2 and 7.B.2). The regions of the S or L RNA with a high 
mutation frequency index for type 1 mutations are shown as closed blue areas while regions 
with a high mutation frequency index for type 2 mutations are shown as open, red outlined, 
areas. Mutations of type 2 found outside blue regions, identified at S RNA positions GPC168, 
GPC427, GPC446 and N47, and L RNA positions L76, L936, L1156, could be more confidently 
involved in the virulence attenuation process.  
Furthermore, we searched for the presence of some of the type 2 mutations in a set of field 
samples. These Junín virus strains were isolated in the endemic area from human cases and 
captured rodents from the period of 1963-1991. Four genomic regions were selected for the 
analysis: i) G fragment: comprises the nucleotide positions 303 to 941 (in the glycoprotein 
precursor coding sequence), ii) N fragment, located between nucleotides 1632 and 2095 (in 
the nucleoprotein coding sequence), iii) L1 fragment, comprise between 1086 and 2005 
nucleotide residues, covering the totality of RNA polymerase-RNA dependent IV motif, and 
iv) L2 fragment, covering the residues comprises between the 4234 and 4890 positions (C 
terminal of motif II). These regions include some of the type 2 mutations detected in 
previously. For 13 field JUNV strains, these regions were amplified and sequenced. 
In the alignments of the different in silico translated proteins from sequenced fragments we 
search for the positions in which it was possible to identify variations between strains. 
However, for the positions included in this analysis, the variation observed between the 
attenuated JUNV strains was also present in some of the new field samples, taken from both 
rodents and human cases. As example, in Table 3 we showed some of the positions with 
type 2 mutations (potentially related to the virulence attenuation process) within the G 
fragment. The analyzed region spanned positions between residues 49 and 193 of 
glycoprotein 1 (G1), as well as the first 11 amino acids from glycoprotein 2 (G2), after the 
consensus sites for glycoprotein processing observed in other arenaviruses (York et al., 
2004). As a consequence, the relative importance of these variations in the attenuation 
process should be re-evaluated. 
3.2 Non coding regions 
It has been previously suggested that changes in the intergenic region could play a role in 
the attenuation processes of arenaviruses (Wilson & Clegg, 1991). However, our sequence 
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analysis of the intergenic regions from XJ13, XJ#44 and Candid#1 revealed 100% 
conservation in both genomic RNAs. If nucleotide changes were not tolerated in this region, 
it could suggests that a major evolutive constraint is operating, perhaps related to the 
calculated secondary structure conformation and its proposed function in the transcription 
regulation process (Franze-Fernández et al., 1993; Tortorici et al., 2001a). Furthermore, the 
non-coding regions at the genomic ends are highly conserved among analyzed strains, 
varying between 93% and 97% of nucleotide sequence homology. The 3’ non-coding region, 
which in the virions shows a high degree of complementarity with the 5’ non-coding region, 
exhibits very few differences in independent clones of each strain and varies only slightly 
from one strain to another. 
On the other hand, when infected cell-derived RNAs were sequenced, a high degree of 
sequence variability has been observed at the 5’ and 3’ non-coding regions among RNAs 
derived from the same strain. We did a RACE analysis to observe specifically the genomic 
or the antigenomic forms of Junín virus RNAs. For example, after RACE analysis, a series of 
non-template bases were found at the 5´end of Candid#1 L and S RNAs. In the comparison 
between the 5´end of genomic RNAs and the 3´end of antigenomic RNAs (which are used as 
a template for the former), at least one additional guanine is present in all 5’ end genomic 
clones comprising extra bases, similarly as detected for other arenavirus (Polyak et al., 1995). 
The 3´ RACE analysis of genomic S and L RNA obtained from Candid#1 infected cells 
rendered several clones harboring short deletions. RNA secondary structure analysis from 
Candid#1 S and L RNA predicted a panhandle structure between 5´ and 3´ ends of both 
genomic RNAs. Deletions at the 3´ end were localized inside the panhandle (Figure 8). 
 
Fig. 8. End sequence determination of Junín virus, Candid#1 strain RNAs. Panhandle 
structures predicted for Candid#1, L and S RNAs. Shadowed with gray is the region present 
in all 3´-end clones. Sequence logos representing the distribution in the last nucleotides of 
3´-end and 5´-end sequence of L and S RNA clones as determined by a genome specific 
RACE technique. Shadowed box corresponds to an additional extended G of the genomic 
sequence. 
These results are consistent with a model that suggests the use of cellular RNAs to prime the 
viral RNA synthesis and the use of 5´ end sequences from viral RNA into a non-completed 
panhandle structure, as template for the 3´ end sequence completion. This heterogeneity 
could have arisen from different transcription-related editing of the subgenomic RNAs, 
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reported previously for other arenaviruses (Garcin & Kolakofsky, 1992). However, the 
involvement of these regions in the attenuation process remains to be evaluated. 
Interestingly, comparison between 5´ and 3´ ends sequences from both genomic RNAs (S 
and L segments), show highly conserved positions. These positions could be related with 
the minimal promoter sequence. The 5’ and 3’ non-coding sequences from Candid#1 S RNA 
have approximately 80 nucleotides in length, similarly to the 5’ end from L RNA non-coding 
sequences. However, 3’ non-coding sequences from L RNA have only 30 nucleotides in 
length. When comparing the 80 nucleotides from non-coding sequences, the homology 
between 5´ end sequences of the L and S RNAs was 60% while that from 3’ end sequences 
was only 50%. However, if we compare only 30 nucleotides from the 3’ end of both genomic 
RNAs the homology of this region ascends to 71%. Because both, genomic or antigenomic, 
non-coding regions must be recognized by the viral RNA polymerase to complete the viral 
replicative cycle, the promoter region should be present in the first 30 nucleotides of the 
antigenomic L RNA. Genomic ends of arenaviruses comprise a highly conserved region of 
19 nucleotides, called arena region. Outside this region the 3’ end of Junín virus L RNA 
comprises only 11 nucleotides (GCTCAAGTGCC). These nucleotides show a high degree of 
homology with two regions of S RNA 3’ end sequences. Thus, two boxes at the S RNA 
appear to match with a unique box at the L RNA. The S RNA boxes (positions 1-12 and 35-
45 in the alignment) could be related to translation or transcription processes. Other 
arenaviruses have similar characteristics at their genomic ends. For example, an extensive 
analysis using the genomic sequences from other New World arenaviruses belonging to B1 
subclade (Machupo, Junín and Tacaribe viruses; Flanagan et al., 2008), show that the 38-46 
box (GCUCAAGUG for the Junín virus L RNA and GCUCAGUG for the Junin virus S RNA) 
was conserved in the group (Goñi et al., 2010). Consequently, it is possible that a sequence 
motif could be present at the 3’ end of both genomic RNAs of arenaviruses. Furthermore, for 
Junín, Machupo and Tacaribe viruses, this motif, described by the sequence GSYC(A)1-
2GUR, shows a relative degree of conservation in position in the RNA secondary structure 
calculated by bioinformatic tools. 
3.3 Phylogeny 
An independent parsimony analysis was performed for each arenavirus gene (GPC, N, Z 
and L). An additive tree-file was constructed adding the obtained parsimony tree-files from 
each gene in order to obtain a consensus tree for the four genes. Clades and subclades of Old 
World and New World arenaviruses are in accord with Charrell et al. (2008). Phylogenetic 
analysis show that all Junín virus strains (Candid#1, XJ13, XJ#44, MC2 and Romero) 
grouped together with other hemorrhagic New World arenaviruses. Furthermore, the 
phylogeny correlates with the genealogy of the vaccine strain, Candid#1, and a small set of 
nucleotide changes seems to be central to define the phenotypic variation from virulence to 
attenuation. If this is confirmed in a more extensive study, any surveillance program 
designed to monitor the natural vaccine variations should search for possible point 
mutations at those positions related with attenuation. 
4. Conclusions 
Candid#1, the most attenuated Junín strain, has a set of putative attenuation markers into 
the GPC, N and L protein ORFs. Some of these changes could be associated more 
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confidently with the attenuated phenotype. Initially, we focussed on changes detected into 
those genomic regions harboring a low wild type mutation frequency index (GPC168, GPC427, 
GPC446, N47, L76, L936, L1156).  
At present, we have made bioinformatic and phylogenetic analysis on the putative 
attenuation markers. For L proteins, the group of Vieth (Vieth et al., 2004) describe four 
conserved regions among all arenaviruses. Inside of the region III, Lan and coworkers (Lan 
et al., 2008), found the polymerase domain, and proposed the presence of four motifs: A, B, 
C and D. In this region we detect only one change (RKK), at the 1156 position. Although 
this change is classified as conservative, it could be related to the attenuation process 
because this region seems not to sustain mutations in nature. Other L changes are located 
between region II and III (L936, LLP) or inside region I (L76, HYY). Change L936, in 
spite of being present in a region of high index for type 2 mutations, could only be 
associated with a structural change of the Candid#1 derived L protein based on the 
structural characteristics of the Proline residue. L76 change falls near the putative ATP/GTP 
binding site (P-loop) predicted using the Expasy web site (www.expasy.ch). Although our 
results, suggesting the involvement of the RNA polymerase in attenuation of virulence are 
preliminary, they are consistent with reports on other viruses (Endres et al., 1991; Lan et al., 
2008; Riviere et al., 1985a). Furthermore, some changes in the structural proteins, 
nucleoprotein and both mature glycoproteins, could be related with the attenuation of 
virulence. The carboxyl-terminus of N protein, which contains a zinc binding domain 
(Tortorici et al., 2001b) is highly conserved, and the found N47 change (VVE) falls 
outside this region and would be associated with another characteristic of the protein, as the 
ability to oligomerize (N-N interactions, Levingston Macleod et al., 2011). Therefore, N 
protein has a dual function during the virus life cycle. First, it is involved in essential steps 
of genome replication, promoting the synthesis of the full-length antigenomic copy of S 
RNA, and second, it associates with the genomic RNA to form the nucleocapsid. For the 
glycoprotein precursor, we found a mutation in the carboxyl-terminus of G1 (GPC168, 
TAA). This change affects directly the conserved sequence (N166R167T168K169) for the 
principal N-glycosylation site predicted by NETNGLYC 1.0. G2 has three domains, the outer 
(caboxi-terminus) domain located outside the virion, the transmembrane domain and the 
inner (amino-terminus) domain, located inside the virion. The outer domain interacts with 
G1, the transmembrane domain interacts with the signal peptide, and the inner domain 
could interact with Z or the nucleocapsid (Capul et al., 2007; York et al., 2004). G2 changes 
fall inside the transmembrane domain (GPC427, FFI) or at the cytoplasmic tail (GPC446, 
TTS) and could affect such important interactions.  
In terms of distribution of the potential attenuation markers, we find a lower level of 
nucleotide sequence conservation in the S RNA than in the L RNA, indicating a faster rate of 
evolution in the S polypeptides. Lan and colaborators (Lan et al., 2008) showed the genome 
comparison of virulent and avirulent strains of the Pichinde arenavirus, and found a lower 
number of attenuation related mutations, but at comparable genomic regions. If we 
compared only the field strains of Junín virus (MC2, Romero, IV4454 and XJ13), the 
mutations distribute markedly differently among large and small segments. We considered 
specific changes for MC2, Romero or IV4454 when their sequences differed from XJ13 
sequence, and specific changes for XJ13 when its sequence differed from all three Junín virus 
strains. Analyzing the protein sequences of the field strains, there were 45 divergence sites 
for the S RNA ORFs and 48 for the L RNA ORFs. Interestingly, 96% (46/48) of L RNA-
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derived divergence sites were XJ13-specific changes, and only 9% (4/45) of this type of 
changes were present when S RNA-derived divergence sites were analyzed. 
The increasing sequence information from complete arenavirus genomes, especially of the 
JUNV species, contributed to the identification of putative markers of virulence attenuation. 
In this sense, Goñi et al. (2010) and the recent paper of Albariño et al. (2011a) publish 
sequence data involving seven members of the vaccine strain family (XJ13, XJ17, XJ34, XJ39, 
XJ44, XJ48 and Candid#1 strains).  To investigate the role of different point mutations in the 
virulence attenuation process Albariño et al., (2011a) used a reverse genetics system for 
JUNV they developed (Albariño et al., 2011b). They show that point mutations located at the 
Candid#1 GPC ORF, conferred the attenuated phenotype.  
Furthermore, with the objective of analyzing the mutation distribution in nature, Goñi et al. 
(2011) designed a molecular technique of RT-Nested-PCR and afterwards used with rodent 
and human samples from the endemic area. A previous study, performed on different 
genomic regions with another group of strains (García et al., 2000), suggested a high degree 
of homology for the S RNA derived ORFs. The protein sequences we obtained by in silico 
translation of the four fragments were analyzed with different tools.  
We compare the data collected for the GPC derived sequences (G fragment) after the results 
included in our studies and in the Albariño et al. (2011a) paper. In the Table 3 we show the 
positions with residue differences between G fragments encoded proteins from JUNV 
strains belonging to the vaccine family and JUNV strains collected from field samples. As 
noted above, the G fragment covered the sequence involved in the cleavage between G1 and 
G2 proteins. The possible recognition site is formed by the sequence QLPRRSLK251↓AFF 
(Beyer et al., 2003), or between the L250 and K251 (Lenz et al., 2001), and cutting is done by the 
protease SKI-1/S1P. The sequenced samples reported here showed a high conservation 
degree in this zone. Only for isolate H_FHA5054, changes were observed at positions 244 
and 245 (QH and LF respectively), although it is possible that these modifications may 
not affect the recognition site. Some of the changes observed in the G fragment (63% of G1), 
could be related to the host jump process of a particular strain from rodents to humans 
(probably derived from the receptor affinity variation in the human isolates). These changes 
could be related to changes in the virulence (attenuation or increase) trough modification of 
the cellular tropism. Another important site in this fragment was determined by NETGLYC 
1.0, comprising the target sequence N166R167T168K169 involved in the N-glycosylation of this 
protein. By observing the distribution of this target in the different isolates it can be seen 
that only 65% of the field strains have the target sequence, while the other 35% have an 
alanine residue (A168).  
The bioinformatics studies did not show important changes in the protein properties at 
this region (data not shown). On the other hand, a recent study resolved the importance of 
two positions strongly related to the N- glycosylation for JUNV and MACV (Bowden et 
al., 2009). It was found that both residues and their environment are highly conserved. In 
any case, it was recently shown for LCMV, that each N-linked glycan in the arenavirus 
glycoprotein is involved in GPC expression, fusion with the host receptor and infectivity 
(Bonhomme et al., 2011). Interestingly, all XJ13-derived attenuated strains have an A168 
mutation. 
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107 S S S S S S S S T S S S S S S S S S S T T T S 
109 Q Q Q Q Q Q Q K M M Q Q Q M Q Q M M Q M M M Q 
111 S S S S S S S S T S S S S S T S S S S T T T S 
116 A A A A A A A A A E A A A A A A A A A A A A A 
121 Q Q Q Q Q Q Q E Q Q Q Q E Q Q Q Q Q Q Q Q Q Q 
125 I I I I I I I I V I I I I I V I I I I V V V I 
133 S S S S S S S S S S S S S N S S N N S S S S S 
143 W W W W W W W W W W W W W W W W W W W R R R W 
151 A A A A A A A A A A A A A A A A A A A V V V A 
157 H H H H H H H Y Y H H H H H H H H H H H H H H 
168 T A A A A A A T T T A A T T A A T T A T T T A 
184 V V V V V V V I V V V V V V V V V V V V V V V 
186 E E E E E E G E E E G G E E G G E E G E E E G 
206 S S S S S S P S S S P P S S P P S S P S S S P 
208 P L L L L L L L L L L L L L L L L L L L L L L 
209 N N N N N N N D S N N N N N N N N N N S S S N 
244 Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q H Q 
245 L L L L L L L L L L L L L L L L L L L L L F L 
Letters in bold indicate the residues that are different from the residue present in the reference XJ13 
strain. The amino acids are shown in the one letter code. The type 2 mutations between vaccine family 
strains are shadowed in grey. 
Table 3. Positions with residue differences between G fragment encoded proteins. 
We hypothesized that those mutations found among field strains are of minor importance in 
the phenomenon of virulence attenuation. None of the type 2 mutations here analyzed, were 
absent in natural samples. In this context, the data presented in Table 3, could indicate that 
none of the mutations found in G1 is important to define the attenuated phenotype. This 
result is in accordance with those published by Albariño et al., (2011a), who located the most 
important mutations for attenuation in G2.  
In summary, the present work shows a set of mutations that could be related to the 
virulence attenuation phenomenon. Furthermore, most of both described types of mutations 
(type 1 and type 2) could be grouped into a few regions (Figure 7). In order to analyze 
genomic variability in Junín virus and to search for the presence of mutations of type 1 or 
type 2 among field strains, we designed a set of primers that are used in a rapid method, 
based on RT-PCR and nucleotide sequencing. This method could be useful in order to 
observe the biodiversity in nature or to develop an epidemiologic surveillance program of 
vaccinated people. The information accumulated by sequence analysis of viral genomes 
with different degrees of virulence will certainly serve as a starting point to study this 
biological phenomenon. Our results contribute to the generation of the sequence data of 
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field isolates that should prove highly useful in the selection of residues potentially involved 
in different viral survival mechanisms and are a potential target for mutagenesis studies. 
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